Ronald Silver, Principal Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 35,416 shares at $4.60 ($163K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Scheduled sale ($163k) by Principal Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2025-08-13 | $2K | — | Filing → |
| IRWD | SELL | 2025-02-12 | $21K | — | Filing → |
| IRWD | SELL | 2024-08-14 | $13K | — | Filing → |